asa glp-1 agonist guidelines A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations
Description
Mark Kennedy has received honoraria for serving as a speaker for and advisory board member of Eli Lilly
Below are the monthly prices for each drug
They are indicated for type 2 diabetes management, weight reduction in obesity, and cardiovascular risk reduction, with ongoing investigation into metabolic dysfunction-associated steatohepatitis, chronic kidney disease, and heart failure with preserved ejection fraction
Leiter, L
May 2021
The initial dosing starts at 0.25 mg per week and is gradually increased at 4-week intervals to 0.5, 1.0, 1.7 mg, and finally to a maximum dose of 2.4 mg per week
